What's new

Quarterly System Demo – Q1 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2025, 09:00 (CET) to 26 March 2025, 11:30 (CET)

Quarterly System Demo – Q1 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2025, 09:00 (CET) to 26 March 2025, 11:30 (CET)

Feb 13, 2025 - 14:35
 0
Quarterly System Demo – Q1 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2025, 09:00 (CET) to 26 March 2025, 11:30 (CET)
Quarterly System Demo – Q1 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2025, 09:00 (CET) to 26 March 2025, 11:30 (CET)
Read More

Tags:

Previous Article

Amgen ends Ideaya cancer combination trial after partner unveils rival molecule

Next Article

Ingredion cautious after strong ’24 growth

Related Posts

Linguistic review - Human

Linguistic review - Human

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 24, 2025  0

Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0